Staar Ovarian Cancer

Analysis

Staar Ovarian Cancer is a registered charity in United States, based in Chicago, IL. It received its IRS tax-exemption ruling in March 2020, 6 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Staar Ovarian Cancer reported income of $400k and spending of $277k, leaving 31% of income unspent that year. Across the 3 years on record, from December 2021 to December 2023, income grew from $168k to $400k (+137%), an average of +54% a year. The sharpest change came in the year to December 2022, when income rose by 85%. Over the whole period it spent 94% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Staar Ovarian Cancer sits at the 51st percentile: it is larger than about 51% of them. Against every charity in United States with reported income it ranks in the 67th percentile, and in the 66th percentile within IL. Charities of a similar size with the same main cause include C&s Patient Education Foundation ($400k), Domus Pacis Family Respite Inc ($400k) and Duke Medicine Global Support Corp ($399k).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 82% and program service revenue 18% of the total. At year end it held assets of $448k against liabilities of $299k, net assets of $149k.